Skip to main content

Jinwon Kim

Seoul National University · Medicine

About the Lab

Professor Jinwon Kim's research lab specializes in translational cancer research, focusing on tumor microenvironment, treatment response prediction, and molecular mechanisms underlying gastrointestinal cancers. The lab integrates advanced imaging techniques, such as radiomics and texture analysis, with molecular pathology and stem cell biology to improve patient stratification and therapeutic outcomes. Key research directions include understanding the role of immune-related signaling pathways (e.g., EGFR/HER2/PI3K), tumor heterogeneity, and DNA damage response (e.g., ATM/MSI) in gastric and colorectal cancers.

gastric cancercolorectal cancertumor microenvironmentradiomicsmolecular pathology

Research Overview

Papers
420
Total Citations
9,775
Papers (5y)
181
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
181total
2022
2023
2024
2025
2026
Citations per year (5y)
4,207total
20222023202420252026

Selected Papers

15
1
Article|249 citations·2014
Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer
Jin Won Kim, Kyung Han Nam, Sang-Hoon Ahn, Do Joong Park, Hyung‐Ho Kim, Se Hyun Kim, Hyun Chang, Jeong‐Ok Lee, Yu Jung Kim, Hye Seung Lee, Jee Hyun Kim, Soo‐Mee Bang
SJR Q1Gastric CancerOA
OncologyMedicine
2
Article|171 citations·2022
Kidney Decellularized Extracellular Matrix Enhanced the Vascularization and Maturation of Human Kidney Organoids
Jin Won Kim, Sun Ah Nam, Jawoon Yi, Jae Yun Kim, Jong‐Young Lee, Seo‐Yeon Park, Tugce Sen, Yoo‐mi Choi, Jae Yeon Lee, Hong Lim Kim, Hyung Wook Kim, Jihwan Park
SJR Q1Advanced ScienceOA

Kidney organoids derived from human pluripotent stem cells (hPSCs) have extensive potential for disease modelling and regenerative medicine. However, the limited vascularization and immaturity of kidney organoids have been still remained to overcome. Extracellular matrix (ECM) can provide mechanical support and a biochemical microenvironment for cell growth and differentiation. Here in vitro methods using a kidney decellularized extracellular matrix (dECM) hydrogel to culture hPSC-derived kidney

SurgeryMedicine
3
Article|117 citations·2008
The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines
Jin Won Kim, Hwang‐Phill Kim, Seock‐Ah Im, Soyeong Kang, Hyung Seok Hur, Young‐Kwang Yoon, Do‐Youn Oh, Jee Hyun Kim, Dong Soon Lee, Tae‐You Kim, Yung‐Jue Bang
SJR Q1Cancer Letters
OncologyMedicine
4
Article|112 citations·2016
Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer
Yeonjoo Choi, Jin Won Kim, Kyung Han Nam, Song-Hee Han, Ji‐Won Kim, Sang-Hoon Ahn, Do Joong Park, Keun‐Wook Lee, Hye Seung Lee, Hyung‐Ho Kim
SJR Q1Gastric CancerOA
OncologyMedicine
5
Article|73 citations·2018
Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
Changhoon Song, Joo-Hyun Chung, Sung‐Bum Kang, Duck-Woo Kim, Heung‐Kwon Oh, Hye Seung Lee, Jin Won Kim, Jin Won Kim, Keun‐Wook Lee, Jee Hyun Kim, Jee Hyun Kim, Kim Js
SJR Q1CancersOA

There is ongoing debate regarding the significance of complete or near-complete response after neoadjuvant chemoradiotherapy (CRT) for rectal cancer. This study assessed the prognostic value of the Dworak tumor regression grade (TRG) following neoadjuvant CRT and surgery primarily in patients with pathological stage (ypStage) II and III rectal cancer. The records of 331 patients who underwent neoadjuvant CRT followed by total mesorectal excision between 2004 and 2015 were retrospectively reviewe

OncologyMedicine
6
Article|66 citations·2020
Korean red ginseng for cancer-related fatigue in colorectal cancer patients with chemotherapy: A randomised phase III trial
Jin Won Kim, Sae Won Han, Y. Choi, Ik-Joo Chung, Jong Gwang Kim, Kyung Hee Lee, Keon Uk Park, Sun Kyung Baek, Sang Cheul Oh, Myung Ah Lee, Doyeun Oh, Byoungyong Shim
SJR Q1European Journal of CancerOA

KRG could be safely combined with mFOLFOX-6 chemotherapy in colorectal cancer patients, and reduced CRF compared with placebo.

Molecular BiologyBiochemistry, Genetics and Molecular Biology
7
Article|59 citations·2021
A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy
In Sil Choi, Ki Hwan Kim, Ju Hyun Lee, Koung Jin Suh, Ji‐Won Kim, Jin Hyun Park, Yu Jung Kim, Jin-Soo Kim, Jee Hyun Kim, Jin Won Kim
SJR Q1European Journal of Cancer
SurgeryMedicine
8
Article|54 citations·2016
Tumor Heterogeneity in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer Assessed by CT Texture Analysis: Association with Survival after Trastuzumab Treatment
Sung Hyun Yoon, Young Hoon Kim, Yoon Jin Lee, Jihoon Park, Jin Won Kim, Hye Seung Lee, Bohyoung Kim
SJR Q1PLoS ONEOA

BACKGROUND: Image texture analysis is a noninvasive technique for quantifying intratumoral heterogeneity, with derived texture features reported to be closely related to the treatment outcome of tumors. Gastric cancer is one of the most common tumors and the third leading cause of cancer-related deaths worldwide. Although trastuzumab is associated with a survival gain among patients with human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer, optimal patient selection i

Radiology, Nuclear Medicine and ImagingMedicine
9
Article|51 citations·2013
The early discontinuation of palliative chemotherapy in older patients with cancer
Jin Won Kim, Yu Jung Kim, Keun‐Wook Lee, Hyun Chang, Jeong Ok Lee, Kwang‐Il Kim, Soo‐Mee Bang, Jong Seok Lee, Cheol‐Ho Kim, Jee Hyun Kim, Jee Hyun Kim, Jee Hyun Kim
SJR Q1Supportive Care in Cancer
Geriatrics and GerontologyMedicine
10
Article|49 citations·2013
Ataxia‐telangiectasia‐mutated protein expression with microsatellite instability in gastric cancer as prognostic marker
Jin Won Kim, Seock‐Ah Im, Min A Kim, Hyun Jin Cho, Dae Won Lee, Kyung‐Hun Lee, Tae‐Yong Kim, Sae‐Won Han, Do‐Youn Oh, Hyuk‐Joon Lee, Tae‐You Kim, Han‐Kwang Yang
SJR Q1International Journal of CancerOA

The prognostic significance of ataxia-telangiectasia-mutated (ATM) expression in gastric cancer remains unclear. The functional loss of ATM gene exhibits a biologic correlation with microsatellite instability (MSI). In this study, we investigated the significance of ATM expression with MSI by evaluating gastric cancer patients who had underwent curative resection. ATM expression was classified into low ATM expression (-, ±, +) and high ATM expression (++, +++) using immunohistochemistry analysis

Pathology and Forensic MedicineMedicine
11
Article|45 citations·2017
EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release
Koung Jin Suh, Ji Hea Sung, Jin Won Kim, Song-Hee Han, Hye Seung Lee, Ahrum Min, Mi Hyun Kang, Ji Eun Kim, Ji‐Won Kim, Se Hyun Kim, Jeong‐Ok Lee, Yu Jung Kim
SJR Q2OncotargetOA

Inhibition of the EGFR/HER2 signaling pathway, particularly of downstream PI3K activity, suppressed PD-L1 and release of cytokines, suggesting that EGFR/HER2 inhibition may create a more favorable milieu for tumor immunotherapy.

OncologyMedicine
12
Article|37 citations·2011
Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy
Jin Won Kim, Yongjun Cha, Su‐Jung Kim, Sae‐Won Han, Do‐Youn Oh, Se‐Hoon Lee, Dong‐Wan Kim, Seock‐Ah Im, Tae-You Kim, Dae Seog Heo, Yung‐Jue Bang
SJR Q1Supportive Care in Cancer
Pulmonary and Respiratory MedicineMedicine
13
Article|35 citations·2012
The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen.
Jin Won Kim, Seock‐Ah Im, Miso Kim, Yongjun Cha, Kyung-Hun Lee, Bhumsuk Keam, Min A Kim, Sae‐Won Han, Do‐Youn Oh, Tae‐You Kim, Woo Ho Kim, Yung‐Jue Bang
PubMed

AIM: We aimed to clarify the prognostic significance of HER2 positivity in advanced gastric cancer. PATIENTS AND METHODS: The cohort included patients with initially metastatic or recurrent gastric cancer treated with first-line modified FOLFOX-6. The HER2 status was analyzed according to modified scoring criteria specific for gastric cancer. RESULTS: HER2 positivity was shown in 10 out of 114 patients (9.0%). The median time-to-progression (TTP) (4.3 months, 95% confidence interval (CI)=3.6-4.9

Pulmonary and Respiratory MedicineMedicine
14
Article|34 citations·2020
Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer
Jong-Chan Lee, Sang Myung Woo, Dong Woo Shin, Jinkook Kim, Se Yeol Yang, Min Jae Kim, Jin Won Kim, Ji‐Won Kim, Woo Jin Lee, Hyo Soung, Philiip Park, Jaihwan Kim
SJR Q3American Journal of Clinical Oncology

OBJECTIVE: By using the Korean Pancreatic Cancer (K-PaC) registry, we compared the clinical outcomes of FOLFIRINOX (FFX) and gemcitabine plus nab-paclitaxel (GNP) in patients with metastatic pancreatic cancer (MPC). METHODS: We constructed a web-based database of 3748 anonymized patients diagnosed with pancreatic ductal adenocarcinoma. MPC patients who received first-line FFX or GNP were enrolled. Overall survival (OS), progression-free survival, grade III to IV toxicity, and cross-over treatmen

OncologyMedicine
15
Article|33 citations·2018
Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study
Jin Won Kim, Yun‐Gyoo Lee, In Gyu Hwang, Hong Song, Su Jin Koh, Yoon Ho Ko, Seong Hoon Shin, In Sook Woo, Soojung Hong, Tae‐Yong Kim, Sun Young Kim, Byung‐Ho Nam
SJR Q1British Journal of CancerOA

BACKGROUND: Older patients have increased risk of toxicity from chemotherapy. Current prediction tools do not provide information on cumulative risk. METHODS: Patients aged ≥ 70 years with solid cancer were prospectively enrolled. A prediction model was developed for adverse events (AEs) ≥ Grade 3 (G3), based on geriatric assessment (GA), laboratory, and clinical variables. RESULTS: 301 patients were enrolled (median age, 75 years). Median number of chemotherapy cycles was 4. During first-line c

Geriatrics and GerontologyMedicine

Research Areas

OncologyPulmonary and Respiratory MedicineSurgeryMolecular BiologyGeriatrics and GerontologyHematology

Dive deeper into Jinwon Kim's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.